Clinical Trial Update: A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention [Phase 3]

View source ↗

Summary

Phase 3 trial comparing prasugrel with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention provides pivotal efficacy a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• EFFIENT (prasugrel hydrochloride)
• Plavix (clopidogrel)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Coronary Arteriosclerosis, Acute Coronary Syndromes | Phase 3 | Status: COMPLETED | Results posted: 2010-09-16